Clear Search sequence regions


  • humans (1)
  • like (10)
  • meta analysis (1)
  • patients (2)
  • sodium (2)
  • therapies (1)
  • Sizes of these terms reflect their relevance to your search.

    Kidney stones are the most common condition affecting the kidney, and characterized by a high rate of recurrence. Thiazide and thiazide-like diuretics (thiazides) are commonly prescribed to prevent the recurrence of kidney stones. This review offers a comprehensive up-to-date assessment of the evidence supporting the use of thiazides for kidney stone recurrence prevention, highlights potential harms associated with treatment, and identifies areas of knowledge that require further investigation. The clinical routine to prescribe thiazides for kidney stone prevention has recently been challenged by the findings of the large NOSTONE trial that failed to show superiority of hydrochlorothiazide at doses up to 50 mg daily over placebo in preventing a composite of clinical or radiological recurrence in patients at high risk of recurrence. Yet, adverse events such as new onset diabetes mellitus and gout were more common in patients receiving hydrochlorothiazide compared to placebo. As demonstrated by a novel meta-analysis presented in this review encompassing all randomized placebo-controlled trials with thiazide monotherapy, current trial evidence does not indicate that thiazide monotherapy is significantly better than placebo in preventing kidney stone recurrence. Given the limited efficacy and possible adverse effects, we advocate for a restrictive use of thiazides for kidney stone recurrence prevention. Clearly, there remains a high unmet medical need for effective, targeted therapies to prevent recurrence of kidney stones. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.

    Citation

    Matteo Bargagli, Sven Trelle, Olivier Bonny, Daniel G Fuster. Thiazides for kidney stone recurrence prevention. Current opinion in nephrology and hypertension. 2024 Jul 01;33(4):427-432

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38606682

    View Full Text